Overview

MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine wether Mesna could prevent contrast-induced nephropathy
Phase:
Phase 2
Details
Lead Sponsor:
University of Ulm
Treatments:
Mesna